Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara J Broadhurst

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trends in Parasitology|April 3, 2012
Helminthic therapy: improving mucosal barrier functionMartin J Wolff, Mara J Broadhurst, P'ng Loke
Science Translational Medicine|December 3, 2010
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patientMara J Broadhurst, Jacqueline M Leung, Vikram Kashyap, et al.
Protein Science : a Publication of the Protein Society|June 30, 2021
CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domainJanani Prahlad, Lucas R Struble, William E Lutz, et al.
Plos Pathogens|August 29, 2012
Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in miceMara J Broadhurst, Jacqueline M Leung, K C Lim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Discordance between peripheral and colonic markers of inflammation during suppressive ARTRichard M Dunham, Ivan Vujkovic-Cvijin, Steven A Yukl, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 CellsSatish Sagar, Ashok Kumar Rathinavel, William E Lutz, et al.
Science Translational Medicine|July 12, 2013
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismIvan Vujkovic-Cvijin, Richard M Dunham, Shoko Iwai, et al.
Clinical and Translational Medicine|February 26, 2021
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike proteinSatish Sagar, Ashok Kumar Rathinavel, William E Lutz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trends in Parasitology|April 3, 2012
Helminthic therapy: improving mucosal barrier functionMartin J Wolff, Mara J Broadhurst, P'ng Loke
Science Translational Medicine|December 3, 2010
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patientMara J Broadhurst, Jacqueline M Leung, Vikram Kashyap, et al.
Protein Science : a Publication of the Protein Society|June 30, 2021
CyDisCo production of functional recombinant SARS-CoV-2 spike receptor binding domainJanani Prahlad, Lucas R Struble, William E Lutz, et al.
Plos Pathogens|August 29, 2012
Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in miceMara J Broadhurst, Jacqueline M Leung, K C Lim, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Discordance between peripheral and colonic markers of inflammation during suppressive ARTRichard M Dunham, Ivan Vujkovic-Cvijin, Steven A Yukl, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 CellsSatish Sagar, Ashok Kumar Rathinavel, William E Lutz, et al.
Science Translational Medicine|July 12, 2013
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolismIvan Vujkovic-Cvijin, Richard M Dunham, Shoko Iwai, et al.
Clinical and Translational Medicine|February 26, 2021
Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike proteinSatish Sagar, Ashok Kumar Rathinavel, William E Lutz, et al.
Pageof 1